Santen Pharmaceuticals

Why Santen’s PRESERFLO MicroShunt could mean “fewer sleepless nights for glaucoma surgeons”

Glaucoma expert Julián García Feijóo shares their experiences with the PRESERFLO MicroShunt

Santen Pharmaceutical’s Siân Boisseau shares the company’s vision for achieving sustainability in eye care

Early glaucoma surgery may be the best option for some patients – but which procedure to choose, for which patients, and when?

GlaucomaFest: the first of its kind in medical education, providing a brand new, immersive virtual experience for ophthalmologists in Europe

Stefano Barabino explains how the pandemic is affecting ocular surface health

Is PRESERFLO™ MicroShunt a viable and predictable alternative to trabeculectomy?

Ophthalmology is now ready to embrace gene therapy technologies that promise a stream of novel products for unmet medical needs

How are technological innovations shaping the present – and future – of ophthalmology?

Is artificial intelligence tomorrow’s answer to screening, management, and treatment? Experts weigh in.

This webinar aims to support the effective management of glaucoma across the whole 24 hours of the day.

This webinar provides an overview on the latest developments in diagnosis and management of glaucoma.

This webinar will discuss updated target IOP algorithms in the treatment of glaucoma

This webinar is sponsored by Santen and will discuss the role of compliance in medical therapy of glaucoma